In July 2022 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the Athlete Aishwarya B. after her sample tested positive for the prohibited substance Enobosarm (Ostarine).
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete denied the intentional use of the substance and asserted that she was tested before without issues. She acknowledged that she had used Ostarine tablets in order to recover from an injury, recommended by another athlete.
The Panel finds that the presence of the prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation. The Panel did not accept the Athlete's explanation and concludes that she intentionally had used the prohibited substance.
Therefore the ADDPI Panel decides on 13 February 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 18 July 2022.
